Antidote Treatment Nerve Agent Auto-Injector (ATNAA)
JustificationAwarded
This federal contract opportunity has been awarded to on December 5, 2025.
Award amount pending confirmation
Award Information
DEPT OF DEFENSE awarded this contract to for on December 5, 2025, as part of federal procurement initiatives.
This award is part of federal acquisition procurement activities.
- Award Number
- SPE2DP-26-D-0001
- Award Date
- December 5, 2025
- Status
- Amount Pending
Key Takeaways
- No response deadline specified - contact the agency for details
- Full and open competition - all businesses eligible to bid
- Work to be performed in PHILADELPHIA, PA
- Industry: Biological Product (except Diagnostic) Manufacturing
Contract Details
- Notice ID
- SPE2DP-26-D-0001
- Opportunity Type
- Justification
- Agency
- DEPT OF DEFENSE
- Sub-Agency
- DEFENSE LOGISTICS AGENCY
- Office
- DLA TROOP SUPPORT
- Posted Date
- Wednesday, December 10, 2025
- Response Deadline
- Not specified
- PSC Code
- 6505
- Set-Aside
- Full & Open Competition
- Place of Performance
- PHILADELPHIA, PA, 19111
- Status
- Active
Description
In accordance with FAR 6.305(a), please see attachment for the redacted justification and approval for contract award to Meridian Medical Technologies, LLC for the manufacture and delivery of ATNAA.
Why This Opportunity Matters
The Department of DEFENSE is seeking responses for biological product (except diagnostic) manufacturing in PHILADELPHIA, PA.
Similar Opportunities
Browse Related
Looking for more opportunities?
Browse our full directory of government contracts
